The finding that EGFR amplification in and of itself has the highest specificity for glioblastoma lends additional support to the need to determine specific cutoffs when using FISH to establish the presence of an EGFR amplification versus a chromosome 7 polysomy without EGFR amplification (8). The gene discussed is EGFR; the disease is glioblastoma.